Gene Variant Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Gene TP53
Variant L194F
Impact List missense
Protein Effect loss of function
Gene Variant Descriptions TP53 L194F lies within the DNA binding domain of the Tp53 protein (UniProt.org). L194F confers a loss of function to the Tp53 protein, as demonstrated by decreased Tp53 transactivation activity and decreased binding to Bcl2 in cell culture (PMID: 16443602).
Associated Drug Resistance
Category Variants Paths

TP53 mutant TP53 exon6 TP53 L194F

TP53 mutant TP53 inact mut TP53 L194F

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Transcript NM_000546.6
gDNA chr17:g.7674951G>A
cDNA c.580C>T
Protein p.L194F
Source Database RefSeq
Genome Build GRCh38/hg38
Transcript gDNA cDNA Protein Source Database Genome Build
NM_001407262.1 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126113.2 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001407266.1 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126114 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126112.3 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001407270.1 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001407268.1 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126114.3 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_000546 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_000546.5 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126112 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_000546.6 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126113.3 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001407264.1 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126112.2 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126114.2 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38
NM_001126113 chr17:g.7674951G>A c.580C>T p.L194F RefSeq GRCh38/hg38

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References
TP53 L194F breast cancer sensitive Tanespimycin + Vorinostat Preclinical - Cell line xenograft Actionable In a preclinical study, Tanespimycin (17-AAG) and Zolinza (vorinostat) were synergistic towards tumor growth inhibition in human breast cancer cell line xenograft models harboring TP53 L194F (PMID: 26009011). 26009011
TP53 L194F breast cancer sensitive Tanespimycin Preclinical - Cell line xenograft Actionable In a preclinical study, Tanespimycin (17-AAG) inhibited tumor growth in human breast cancer cell line xenograft models harboring TP53 L194F (PMID: 26009011). 26009011
TP53 L194F breast cancer sensitive Vorinostat Preclinical - Cell line xenograft Actionable In a preclinical study, Zolinza (vorinostat) inhibited tumor growth in human breast cancer cell line xenograft models harboring TP53 L194F (PMID: 26009011). 26009011
TP53 L194F breast cancer sensitive Ganetespib Preclinical - Cell culture Actionable In a preclinical study, Ganetespib inhibited growth of human breast cancer cells harboring TP53 L194F in culture (PMID: 26009011). 26009011